HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shares were up 0.6% during trading on Monday . The stock traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares changed hands during trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The firm’s fifty day moving average price is $25.31 and its 200-day moving average price is $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Read More
- Five stocks we like better than HemaCare
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Nordstrom’s Winning Formula: 3 Factors Behind the Stock’s Success
- Transportation Stocks Investing
- How to See Stocks the Way Warren Buffett Sees Stocks
- What is an Earnings Surprise?
- 3 No-Brainer Stocks to Buy and Hold Long-Term
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
